Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Spreafico

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 15, 2021
The Potential Impact and Usability of the Eighth Edition TNM Staging Classification in Oral Cavity CancerK Chiu, A Hosni, S H Huang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 21, 2025
The prognostic and predictive value of pre-treatment hematologic markers for oropharyngeal carcinoma stratified by HPV status and treated with definitive (chemo) radiationA Hughes, Ca Johnny, S H Huang, et al.
European Journal of Cancer (Oxford, England : 1990)|December 12, 2018
Delayed immune-related adverse events in assessment for dose-limiting toxicity in early phase immunotherapy trialsY Kanjanapan, D Day, M O Butler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 2, 2023
First-in-class Microbial Ecosystem Therapeutic 4 (MET4) in combination with immune checkpoint inhibitors in patients with advanced solid tumors (MET4-IO trial)A Spreafico, A A Heirali, D V Araujo, et al.
Journal of Dental Research|July 9, 2019
HPV Status Improves Classification of Head and Neck Gray Zone CancersJ Ren, W Xu, J Su, et al.
ESMO Open|November 16, 2024
Bespoke ctDNA for longitudinal detection of molecular residual disease in high-risk melanoma patientsS Genta, D V Araujo, K Hueniken, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 2022
Oncology phase I trial design and conduct: time for a change - MDICT Guidelines 2022D Araujo, A Greystoke, S Bates, et al.
ESMO Open|August 3, 2022
Phase I, first-in-human study of MSC-1 (AZD0171), a humanized anti-leukemia inhibitory factor monoclonal antibody, for advanced solid tumorsE Borazanci, A M Schram, E Garralda, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 15, 2021
The Potential Impact and Usability of the Eighth Edition TNM Staging Classification in Oral Cavity CancerK Chiu, A Hosni, S H Huang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 21, 2025
The prognostic and predictive value of pre-treatment hematologic markers for oropharyngeal carcinoma stratified by HPV status and treated with definitive (chemo) radiationA Hughes, Ca Johnny, S H Huang, et al.
European Journal of Cancer (Oxford, England : 1990)|December 12, 2018
Delayed immune-related adverse events in assessment for dose-limiting toxicity in early phase immunotherapy trialsY Kanjanapan, D Day, M O Butler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 2, 2023
First-in-class Microbial Ecosystem Therapeutic 4 (MET4) in combination with immune checkpoint inhibitors in patients with advanced solid tumors (MET4-IO trial)A Spreafico, A A Heirali, D V Araujo, et al.
Journal of Dental Research|July 9, 2019
HPV Status Improves Classification of Head and Neck Gray Zone CancersJ Ren, W Xu, J Su, et al.
ESMO Open|November 16, 2024
Bespoke ctDNA for longitudinal detection of molecular residual disease in high-risk melanoma patientsS Genta, D V Araujo, K Hueniken, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 2022
Oncology phase I trial design and conduct: time for a change - MDICT Guidelines 2022D Araujo, A Greystoke, S Bates, et al.
ESMO Open|August 3, 2022
Phase I, first-in-human study of MSC-1 (AZD0171), a humanized anti-leukemia inhibitory factor monoclonal antibody, for advanced solid tumorsE Borazanci, A M Schram, E Garralda, et al.
Pageof 4